ARCHIVES

New NIH Chief Splits with Predecessors, HEW Brass, Opposes “Balance,” Likes Cancer Program

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | October 24, 1975

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

US, Italy Plan Greater Scientific Collaboration

May 16, 2003